SHERMESE CEASER: Open Payments
NPI 1417660457 · CHALMETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 9 payments from 5 companies in 2025. Trend: 2023 $144 · 2024 $92 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $113 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Exact Sciences Corporation | 2 | $29 |
| Dexcom, Inc. | 1 | $25 |
Products named: MOUNJARO, Kerendia, FARXIGA, Cologuard Collection Kit, Dexcom G6 Transmitter.
Industry payments across LA — which companies pay providers there.
